TOP SCEINCE8 months ago
Risk of secondary cancers after CAR-T cell therapy low, according to large study
A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy — a cell-based cancer treatment...
